10x Genomics (TXG) – Company Press Releases
-
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
-
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
-
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
-
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
-
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
-
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
-
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
-
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
-
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
-
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
-
Torex Gold Reports Successful Breakthrough of Guajes Tunnel Three Months Ahead of Schedule
-
10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
10x Genomics Launches Xenium Catalyst Network
-
Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness
-
High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint
-
10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain
-
Curio Bioscience Responds to Lawsuit
-
Torex Gold Reports Results from 2023 Exploration Drilling Program at Media Luna West
-
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
-
Torex Gold Reports Impressive Results From the 2023 ELG Underground Drilling Program
-
Torex Gold Receives Approval for In-Pit Tailings Deposition
-
Torex Gold Reports Third Quarter 2023 Results
-
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
-
10x Genomics Reports Third Quarter 2023 Financial Results
-
10x Genomics to Present at the Stephens 25th Annual Conference
-
Torex Gold Provides Quarterly Update on Media Luna Project
-
Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain Tumors
-
Torex Gold Reports Q3 2023 Production Results
-
10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023
-
10x Genomics Comments on Second UPC Preliminary Injunction Decision
-
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe
-
10x Genomics Expands Gene Expression Flex Offering with New High-Throughput Multiomic Profiling Kit
-
Torex Gold Reports Results From 2023 Drilling at EPO
-
Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others
-
10x Genomics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
-
10x Genomics Surpasses 100 Xenium Analyzer Shipments
-
10x Genomics Reports Second Quarter 2023 Financial Results
-
Torex Gold Reports Second Quarter Results
-
Torex Gold Provides Third Quarterly Update on Media Luna Project
-
10x Genomics to Report Second Quarter 2023 Financial Results on August 3, 2023
-
CAR T-Cell Study Enabled by 10x Genomics Single Cell Technology Published in Nature Medicine
-
Torex Gold Announces Results of Its 2023 Meeting of Shareholders
-
10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx Products
-
Torex Gold Releases 2022 Responsible Gold Mining Report
-
10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay
-
10x Genomics Wins Permanent Injunction Against NanoString's CosMx Products
-
Torex Gold Reports First Quarter Results
-
Torex Gold Enters Into a Sustainability-Linked Loan
-
10x Genomics Reports First Quarter 2023 Financial Results
-
Torex Gold Provides Second Quarterly Update on Media Luna Project
Back to TXG Stock Lookup
